• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TRIA SOFT; STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TRIA SOFT; STENT, URETERAL Back to Search Results
Model Number M006190321090
Device Problem Device Contaminated During Manufacture or Shipping (2969)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/20/2024
Event Type  malfunction  
Manufacturer Narrative
Block h6: imdrf device code a1802 captures the reportable event of packaging foreign matter.
 
Event Description
It was reported to boston scientific corporation that a tria soft ureteral stent was used during a ureteral stent placement procedure in the ureter performed on (b)(6) 2024.During the procedure, a foreign material contamination was found.It was noted that the foreign material was inside the sterile packaging.The procedure was successfully completed with another tria soft ureteral stent.There were no patient complications reported as a result of this event.A photo of the complaint device was provided and showed that the sterility packaging was compromised.
 
Manufacturer Narrative
Initial reporter fax imdrf device code a1802 captures the reportable event of packaging foreign matter.The returned tria ureteral stent was analyzed, and a visual evaluation noted that the box was returned and the open pouch of an open-end ureteral access catheter with a foreign matter attached with a tape located in the label.No other problems with the device were noted.Taking all available information into consideration, most likely, the device meets all manufacturing specifications required and passed all the controls and inspections, no abnormalities were reported during the assembly process.Therefore, the investigation will be documented as manufacturing deficiency due to problems traced to manufacturing process.
 
Event Description
It was reported to boston scientific corporation that a tria soft ureteral stent was used during a ureteral stent placement procedure in the ureter performed on (b)(6) 2024.During the procedure, a foreign material contamination was found.It was noted that the foreign material was inside the sterile packaging.The procedure was successfully completed with another tria soft ureteral stent.There were no patient complications reported as a result of this event.A photo of the complaint device was provided and showed that the sterility packaging was compromised.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIA SOFT
Type of Device
STENT, URETERAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key19012081
MDR Text Key339022063
Report Number2124215-2024-19198
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K191609
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM006190321090
Device Catalogue Number1983-03
Device Lot Number0031779655
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/15/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received04/01/2024
Supplement Dates Manufacturer Received04/30/2024
Supplement Dates FDA Received05/24/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-